Lars Ottestad
Impact in
- Oncology top 2%
- Bone health and treatments
- Cancer-related Molecular Pathways
- Cancer Risks and Factors
- Cancer Diagnosis and Treatment
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 22
- HER2/EGFR in Cancer Research 8
- Cancer-related Molecular Pathways 5
- Bone health and treatments 5
- Cancer Treatment and Pharmacology 3
-
- Breast Cancer Treatment Studies 7
- Cancer Genomics and Diagnostics 5
- Co-authors
- Jürgen Geisler (7 shared papers)Per Eystein Lønning (8 shared papers)S. Ashley (3 shared papers)John А. Kanis (3 shared papers)Ian Smith (3 shared papers)Alwynne Tidy (3 shared papers)Eugène McCloskey (3 shared papers)Trevor J. Powles (2 shared papers)
- Journals
- British Journal of Cancer (6 papers)Journal of Clinical Oncology (5 papers)Genes Chromosomes and Cancer (3 papers)Acta Oncologica (2 papers)Oncotarget (1 paper)
- Partner nations
- NorwayUnited StatesUnited Kingdom
In The Last Decade
Lars Ottestad
36 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 81
- Oncology 1.2k
- Cancer Research 473
- Genetics 553
- Radiology, Nuclear Medicine and Imaging 290
- Orthopedics and Sports Medicine 108
Countries citing papers authored by Lars Ottestad
This map shows the geographic impact of Lars Ottestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Ottestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Ottestad more than expected).
Fields of papers citing papers by Lars Ottestad
This network shows the impact of papers produced by Lars Ottestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Ottestad. The network helps show where Lars Ottestad may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Ottestad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 306 | |
| 2 | 1996 | 294 | |
| 3 | 2006 | 204 | |
| 4 | Screening for germ line TP53 mutations in breast cancer patients. | 1992 | 152 |
| 5 | 1993 | 150 | |
| 6 | Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer. | 2001 | 100 |
| 7 | 1990 | 98 | |
| 8 | 1992 | 93 | |
| 9 | 1997 | 61 | |
| 10 | 1990 | 58 | |
| 11 | Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer | 2006 | 49 |
| 12 | 2004 | 24 | |
| 13 | 2006 | 18 | |
| 14 | 2016 | 17 | |
| 15 | C-erbB-2 protein and neuroendocrine expression in breast carcinomas. | 1991 | 16 |
| 16 | 2004 | 14 | |
| 17 | 1991 | 13 | |
| 18 | 2012 | 12 | |
| 19 | 1993 | 12 | |
| 20 | 1993 | 12 |
About Lars Ottestad
Lars Ottestad is a scholar working on Oncology, Cancer Research, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Estrogen and related hormone effects (8 papers), Breast Cancer Treatment Studies (7 papers), Cancer Genomics and Diagnostics (5 papers), Cancer-related Molecular Pathways (5 papers), Bone health and treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (473 citations), Genetics (553 citations), Radiology, Nuclear Medicine and Imaging (290 citations) and Orthopedics and Sports Medicine (108 citations). Lars Ottestad has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include Jürgen Geisler, Per Eystein Lønning, S. Ashley, John А. Kanis, Ian Smith, Alwynne Tidy, Eugène McCloskey, Trevor J. Powles, Tone Ikdahl Andersen and Steinar Lundgren. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Genes Chromosomes and Cancer, Acta Oncologica and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.